Kanaya T, Noguchi T, Otsuka F, Asaumi Y, Kataoka Y, Morita Y, Miura H, Nakao K, Fujino M, Kawasaki T, Nishimura K, Inoue T, Narula J, Yasuda S. Optical coherence tomography-verified morphological correlates of high-intensity coronary plaques on non-contrast T1-weighted magnetic resonance imaging in patients with stable coronary artery disease. Eur Heart J Cardiovasc Imaging 2019; 20: 75-83

Tanaka A, Kawaguchi A, Oyama J, Ishizu T, Ito H, Fukui J, Kondo T, Kuroki S, Nanasato M, Higashi Y, Kaku K, Inoue T, Murohara T, Node K. Differential effect of concomitant antidiabetic agents on carotid atherosclerosis: a subgroup analysis of the PROLOGUE study. Heart Vessels 2019; 34: 375-384

Watanabe R, Amano H, Saito F, Toyoda S, Sakuma M, Abe S, Nakajima T, Inoue T. Echocardiographic surrogates of right atrial pressure in pulmonary hypertension. Heart Vessels 2019; 34:477-483

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S. Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis. Genet Med. 2019; 21: 44-52

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S. Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis. Genet Med. 2019; 21: 512-515

Nakamura K, Naito S, Sasaki T, Take Y, Minami K, Kitagawa Y, Motoda H, Inoue M, Otsuka Y, Niijima K, Yamashita E, Sugai Y, Kumagai K, Koyama K, Funabashi N, Oshima S. Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events. Europace 2019; 21: 259-267

Takano N, Amiya E, Oguri G, Nakayama A, Taya M, Nakajima T, Morita H, Komuro I. Influence of atrial fibrillation on oxygen uptake and exercise tolerance in cardiovascular patients; close association with heart rate response. Int J Cardiol Heart Vasc 2019; 22: 84-91

Okura H, Saito Y, Soeda T, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Nishimura K, Miyamoto Y, Ishihara M; J-MINUET investigators. Frequency and prognostic impact of intravascular imaging-guided urgent percutaneous coronary intervention in patients with acute myocardial infarction: results from J-MINUET. Heart Vessels 2019; 34: 564-571

Abe S, Nishino S, Sakuma M, Inoue T. Low endothelial sheer stress -a silent killer. Circ J 2019; 83: 1197-1199

Kajikawa M, Maruhashi T, Kishimoto S, Matsui S, Hashimoto H, Takaeko,Y, Mohamad YF, Kihara Y, Chayama K, Goto C, Noma K, Nakashima A, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y. Target of triglycerides as residual risk for cardiovascular events in patients with coronary artery disease: post hoc analysis of the FMD-J Study A. Circ J 2019; 83: 1064-1071

Okuno T, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M. Admission heart rate is a determinant of effectiveness of beta-blockers in acute myocardial infarction patients. Circ J 2019; 83: 1054-1063

Toyoda S, Arikawa T, Inami S, Nishikawa R, Saito F, Watanabe R, Sakuma M, Kanaya T, Abe S, Inoue T. Patients with congestive heart failure benefit for long-term treatment effects with novel treatment using azosemide compared with furosemide derived from existing retrospective study data -CONTENTED -. J Cardiovasc Pharmacol 2019; 73: 365-372

Abe S, Inoue T. Perspectives of a catheter-based nitric oxide sensor for the evaluation of endothelial function. Vasc Fail 2019; 3: 1-5

Arikawa T, Masuyama D, Waku R, Hirose S, Suwa H, Haruyama A, Inami S, Sakuma M, Toyoda S, Abe S, Nakajima T, Inoue T. Obstructive sleep apnea as a risk factor for the onset and progression of aortic dissection. Vasc Fail 2019; 3: 6-11

Koyabu Y, Abe S, Sakuma M, Kanaya T, Obi S, Yoneda S, Toyoda S, Nakajima T, Inoue T. Short-term safety and mid-term efficacy of prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention. Intern Med 2019; 58: 2315-2322

Saito F, Toyoda S, Arikawa T, Inami S, Watanabe R, Obi S, Sakuma M, Kanaya T, Abe S, Nakajima T, Inoue T. Prediction of acute phase complications in patients with infectious endocarditis. Intern Med 2019; 58: 2323-2331

Inoue K, Kishimoto S, Akimoto K, Sakuma M, Toyoda S, Inoue T, Yoshida K, Shimoda M, Suzuki S. Cancer-associated fibroblasts show heterogeneous gene expression and induce vascular endothelial growth factor A (VEGFA) in response to environmental stimuli. Ann Gastroenterol Surg 2019; 3: 416-425

Nishino S, Sakuma M, Kanaya T, Nasuno T, Tokura M, Toyoda S, Abe S, Nakamura D, Tanaka K, Attizzani G, Bezerra HG, Costa MA, Inoue T. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density. Int J Cardiovasc Imaging 2019; 35: 1971-1978

Tanaka A, Shimabukuro M, Machii N, Teragawa H, Okada Y, Shima KR, Takamura T, Taguchi I, Hisauchi I, Toyoda S, Matsuzawa Y, Tomiyama H, Yamaoka-Tojo M, Yoshida H, Sato Y, Ikehara Y, Ueda S, Higashi Y, Node K, on behalf of the EMBLEM Investigators. Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular diseases: results from the multicenter, randomized, placebo controlled, double-blind EMBLEM trial. Diabetes Care 2019; 42: e159-e161

Yasu T, Shimoyama M, Wada H, Iwakura T, Toyoda S, Kawabe A, Sugiyama T. Homozygous familial hypercholesterolemia with stenosis of the left anterior descending coronary artery successfully treated with weekly low-density lipoprotein apheresis for 16 years without percutaneous coronary intervention. Clin Case Rep. 2019;7: 1608-1611

Sakuma M, Toyoda S, Inoue T, Node K. Inflammation in pulmonary artery hypertension. Vascul Pharmacol 2019; 118-119: 106562.

Okuno T, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Ohshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET investigators. Association of onset-season with characteristics and long-term outcomes in acute myocardial infarction patients: results from the Japanese registry of acute myocardial infarction diagnosed by universal definition (J-MINUET) substudy. Heart Vessels 2019; 34(12): 1899-1908.

Sakuma M, Toyoda S, Hashimoto R, Yazawa H, Masuyama T, Hirose S, Waku R, Hasumi H, Numao T, Abe S, Inoue T. Add-on ezetimibe treatment to low-dose statins vs medium-intensity statin monotherapy in coronary artery disease patients with poorly controlled dyslipidemia. Hypertens Res 2019; 42(12): 1923-1931.

Toyoda S, Haruyama A, Inami S, Arikawa T, Saito F, Watanabe R, Sakuma M, Abe S, Nakajima T, Tanaka A, Node K, Inoue T. Effects of carvedilol vs bisoprolol on inflammation and oxidative stress in patients with chronic heart failure. J Cardiol 2019; 75(2): 140-147.

Ishizuka H, Uematsu A, Mizushima Y, Nozawa N, Katayanagi S, Matsumoto K, Nishikawa K, Takahashi R, Arakawa T, Sawagichi T, Yasuda T, Yamaguchi S, Ogawa H, Shibasaki I, Toyoda S, Hortobagyi T, Fukuda H, Inoue T, Mizushima T, Nakajima T. Blood flow restriction increases the neural activation of the knee extensors during very low-intensity leg extension exercise in cardiovascular patients: a pilot study. J Clin Med 2019; 8(8): 1252.

Nakajima T, Shibasaki I, Sawaguchi T, Haruyama A, Kaneda H, Nakajima T, Hasegawa T, Arikawa T, Obi S, Sakuma M, Ogawa H, Toyoda S, Nakamura F, Abe S, Fukuda H, Inoue T. Growth differentiation factor-15 (GDF-15) is a biomarker of muscle wasting and renal dysfunction in preoperative cardiovascular surgery patients. J Clin Med 2019; 8(10): 1576.

Sawaguchi T, Nakajima T, Haruyama A, Hasegawa T, Shibasaki I, Nakajima Ta, Kaneda H, Arikawa T, Obi S, Sakuma M, Ogawa H, Takei Y, Toyoda S, Nakamura F Abe S, Fukuda H, Inoue T. Association of serum leptin and adiponectin concentrations with echocardiographic parameters and pathophysiological states in patients with cardiovascular disease receiving cardiovascular surgery. PLoS One 2019; 14(11): e0225008.